Overexpression of the mTOR alpha4 phosphoprotein activates protein phosphatase 2A and increases Stat1alpha binding to

Wei Lun Nien1, Shauna M Dauphinee, Lori D Moffat

  • 1Department of Biochemistry & Molecular Biology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 1X5, Canada.

Insights

Alpha4 phosphoprotein enhances protein phosphatase 2A (PP2A) activity by increasing its carboxymethylation. This leads to decreased Stat1alpha methylation and increased Stat1alpha-PIAS1 association, ultimately inhibiting prolactin-induced IRF-1 promoter activity.

Area of Science:

  • Cellular signaling pathways
  • Protein-protein interactions
  • Gene regulation

Background:

  • Alpha4 phosphoprotein is a prolactin (PRL)-downregulated gene product.
  • Alpha4 interacts with protein phosphatase 2A catalytic subunit (PP2Ac).
  • Alpha4 overexpression inhibits PRL-inducible IRF-1 promoter activity via an unknown mechanism.

Purpose of the Study:

  • To elucidate the mechanism by which alpha4 inhibits PRL-inducible IRF-1 promoter activity.
  • To investigate the interaction between alpha4 and PP2Ac.
  • To determine the effect of alpha4 on PP2A activity and downstream signaling.

Main Methods:

  • Stable alpha4-PP2Ac complex formation was assessed in COS-1 cells.
  • PP2Ac carboxymethylation and PP2A activity were measured following alpha4 overexpression.
  • Phosphorylation of eukaryotic initiation factor 4E-binding protein (4E-BP1) and Stat was analyzed.
  • Arginine methylation of Stat1alpha and its association with PIAS1 were evaluated.

Main Results:

  • A stable alpha4-PP2Ac complex was observed, unaffected by rapamycin.
  • Alpha4 overexpression increased PP2Ac carboxymethylation and PP2A activity.
  • Increased PP2A activity correlated with decreased 4E-BP1 phosphorylation.
  • Alpha4 overexpression led to Stat1alpha hypomethylation and increased Stat1alpha-PIAS1 binding.

Conclusions:

  • Ectopic alpha4 enhances PP2A activity in COS-1 cells.
  • Alpha4-mediated PP2A activation results in Stat1alpha hypomethylation and increased association with PIAS1.
  • These molecular events contribute to the inhibition of Stat-mediated transcription and PRL-inducible IRF-1 promoter activity.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...